Fmr LLC Taysha Gene Therapies, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Fmr LLC holds 15,627,822 shares of TSHA stock, worth $78.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,627,822

Previous 15,631,954 0.03%

Holding current value

$78.8 Million

Previous $21.7 Million 66.15%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.13 - $2.9 $4,669 - $11,982	-4,132 Reduced 0.03%	15,627,822 $36.1 Million
Q1 2025 May 12, 2025	SELL	$1.39 - $2.05 $1.02 Million - $1.5 Million	-733,710 Reduced 4.48%	15,631,954 $21.7 Million
Q4 2024 Feb 13, 2025	SELL	$1.27 - $3.24 $2.94 Million - $7.49 Million	-2,312,863 Reduced 12.38%	16,365,664 $28.3 Million
Q3 2024 Nov 13, 2024	SELL	$2.01 - $2.46 $5.09 Million - $6.23 Million	-2,532,109 Reduced 11.94%	18,678,527 $37.5 Million
Q2 2024 Aug 13, 2024	BUY	$2.04 - $4.17 $2.24 Million - $4.59 Million	1,099,919 Added 5.47%	21,210,636 $47.5 Million
Q1 2024 May 13, 2024	SELL	$1.43 - $3.25 $3.33 Million - $7.57 Million	-2,328,407 Reduced 10.38%	20,110,717 $57.7 Million
Q4 2023 Feb 13, 2024	SELL	$1.33 - $2.88 $2.78 Million - $6.02 Million	-2,088,677 Reduced 8.52%	22,439,124 $39.7 Million
Q3 2023 Nov 13, 2023	BUY	$0.63 - $3.66 $14.7 Million - $85.6 Million	23,378,974 Added 2035.03%	24,527,801 $77.5 Million
Q2 2023 Aug 11, 2023	SELL	$0.59 - $0.87 $1.14 Million - $1.69 Million	-1,938,511 Reduced 62.79%	1,148,827 $758,000
Q1 2023 May 11, 2023	SELL	$0.65 - $2.3 $76,429 - $270,443	-117,584 Reduced 3.67%	3,087,338 $2.47 Million
Q4 2022 Feb 13, 2023	SELL	$1.39 - $2.98 $112,396 - $240,965	-80,861 Reduced 2.46%	3,204,922 $7.24 Million
Q3 2022 Nov 10, 2022	SELL	$1.76 - $4.94 $17,434 - $48,935	-9,906 Reduced 0.3%	3,285,783 $6.34 Million
Q2 2022 Aug 12, 2022	BUY	$2.47 - $6.77 $2,143 - $5,876	868 Added 0.03%	3,295,689 $12.3 Million
Q1 2022 May 13, 2022	SELL	$5.22 - $11.86 $5.15 Million - $11.7 Million	-985,673 Reduced 23.03%	3,294,821 $21.5 Million
Q4 2021 Feb 14, 2022	SELL	$11.43 - $19.2 $16.9 Million - $28.4 Million	-1,478,180 Reduced 25.67%	4,280,494 $49.9 Million
Q3 2021 Nov 15, 2021	BUY	$15.82 - $21.57 $1.12 Million - $1.53 Million	71,058 Added 1.25%	5,758,674 $107 Million
Q2 2021 Aug 13, 2021	BUY	$19.29 - $26.38 $110 Million - $150 Million	5,687,616 New	5,687,616 $121 Million

Others Institutions Holding TSHA

# of Institutions

156

Shares Held

244M

Call Options Held

107K

Put Options Held

17K

View Full List

About Taysha Gene Therapies, Inc.

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $244M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

More about TSHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account